ID   DHSD_HUMAN              Reviewed;         159 AA.
AC   O14521; A6ND90; B3KQQ8; E9PIC0; E9PIG3; E9PQI9; Q53XW5; Q6IRW2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   28-JAN-2026, entry version 231.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial;
DE            Short=CybS;
DE   AltName: Full=CII-4;
DE   AltName: Full=Malate dehydrogenase [quinone] cytochrome b small subunit;
DE   AltName: Full=QPs3;
DE   AltName: Full=Succinate dehydrogenase complex subunit D;
DE   AltName: Full=Succinate-ubiquinone oxidoreductase cytochrome b small subunit;
DE   AltName: Full=Succinate-ubiquinone reductase membrane anchor subunit;
DE   Flags: Precursor;
GN   Name=SDHD; Synonyms=SDH4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, PATHWAY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Liver;
RX   PubMed=9533030; DOI=10.1159/000134700;
RA   Hirawake H., Taniwaki M., Tamura A., Kojima S., Kita K.;
RT   "Cytochrome b in human complex II (succinate-ubiquinone oxidoreductase):
RT   cDNA cloning of the components in liver mitochondria and chromosome
RT   assignment of the genes for the large (SDHC) and small (SDHD) subunits to
RT   1q21 and 11q23.";
RL   Cytogenet. Cell Genet. 79:132-138(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.
RX   PubMed=10482792; DOI=10.1016/s0005-2728(99)00071-7;
RA   Hirawake H., Taniwaki M., Tamura A., Amino H., Tomitsuka E., Kita K.;
RT   "Characterization of the human SDHD gene encoding the small subunit of
RT   cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase.";
RL   Biochim. Biophys. Acta 1412:295-300(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, Brain, Lung, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12] {ECO:0007744|PDB:8GS8}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.86 ANGSTROMS) IN COMPLEXES WITH HEME
RP   AND UBIQUINONE, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=37098072; DOI=10.1073/pnas.2216713120;
RA   Du Z., Zhou X., Lai Y., Xu J., Zhang Y., Zhou S., Feng Z., Yu L., Tang Y.,
RA   Wang W., Yu L., Tian C., Ran T., Chen H., Guddat L.W., Liu F., Gao Y.,
RA   Rao Z., Gong H.;
RT   "Structure of the human respiratory complex II.";
RL   Proc. Natl. Acad. Sci. U.S.A. 120:e2216713120-e2216713120(2023).
RN   [13]
RP   VARIANT PPGL1 LEU-81.
RX   PubMed=11156372;
RA   Gimm O., Armanios M., Dziema H., Neumann H.P.H., Eng C.;
RT   "Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II
RT   gene, in nonfamilial pheochromocytoma.";
RL   Cancer Res. 60:6822-6825(2000).
RN   [14]
RP   VARIANTS PPGL1 LEU-81; TYR-92 AND LEU-102.
RX   PubMed=10657297; DOI=10.1126/science.287.5454.848;
RA   Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C.,
RA   Myssiorek D., Bosch A., van der Mey A., Taschner P.E.M., Rubinstein W.S.,
RA   Myers E.N., Richard C.W. III, Cornelisse C.J., Devilee P., Devlin B.;
RT   "Mutations in SDHD, a mitochondrial complex II gene, in hereditary
RT   paraganglioma.";
RL   Science 287:848-851(2000).
RN   [15]
RP   VARIANT PPGL1 CYS-114.
RX   PubMed=11343322; DOI=10.1002/ajmg.1270;
RA   Milunsky J.M., Maher T.A., Michels V.V., Milunsky A.;
RT   "Novel mutations and the emergence of a common mutation in the SDHD gene
RT   causing familial paraganglioma.";
RL   Am. J. Med. Genet. 100:311-314(2001).
RN   [16]
RP   VARIANT PPGL1 TYR-93 DEL.
RX   PubMed=11391796; DOI=10.1002/gcc.1142;
RA   Badenhop R.F., Cherian S., Lord R.S.A., Baysal B.E., Taschner P.E.M.,
RA   Schofield P.R.;
RT   "Novel mutations in the SDHD gene in pedigrees with familial carotid body
RT   paraganglioma and sensorineural hearing loss.";
RL   Genes Chromosomes Cancer 31:255-263(2001).
RN   [17]
RP   VARIANTS PPGL1 TYR-92 AND PRO-139.
RX   PubMed=11391798; DOI=10.1002/gcc.1144;
RA   Taschner P.E.M., Jansen J.C., Baysal B.E., Bosch A., Rosenberg E.H.,
RA   Broecker-Vriends A.H.J.T., van Der Mey A.G.L., van Ommen G.-J.B.,
RA   Cornelisse C.J., Devilee P.;
RT   "Nearly all hereditary paragangliomas in the Netherlands are caused by two
RT   founder mutations in the SDHD gene.";
RL   Genes Chromosomes Cancer 31:274-281(2001).
RN   [18]
RP   VARIANT SER-12.
RX   PubMed=11526495; DOI=10.1038/sj.onc.1204579;
RA   Masuoka J., Brandner S., Paulus W., Soffer D., Vital A., Chimelli L.,
RA   Jouvet A., Yonekawa Y., Kleihues P., Ohgaki H.;
RT   "Germline SDHD mutation in paraganglioma of the spinal cord.";
RL   Oncogene 20:5084-5086(2001).
RN   [19]
RP   VARIANTS SER-12 AND ARG-50.
RX   PubMed=12007193; DOI=10.1002/gcc.10081;
RA   Kytoelae S., Nord B., Elder E.E., Carling T., Kjellman M., Cedermark B.,
RA   Juhlin C., Hoeoeg A., Isola J., Larsson C.;
RT   "Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell
RT   carcinomas, pheochromocytomas, and abdominal paragangliomas.";
RL   Genes Chromosomes Cancer 34:325-332(2002).
RN   [20]
RP   VARIANTS SER-12 AND ARG-50.
RX   PubMed=14500403;
RA   Gimenez-Roqueplo A.-P., Favier J., Rustin P., Rieubland C., Crespin M.,
RA   Nau V., Khau Van Kien P., Corvol P., Plouin P.-F., Jeunemaitre X.;
RT   "Mutations in the SDHB gene are associated with extra-adrenal and/or
RT   malignant phaeochromocytomas.";
RL   Cancer Res. 63:5615-5621(2003).
RN   [21]
RP   VARIANT PPGL1 TYR-92.
RX   PubMed=12000816; DOI=10.1056/nejmoa020152;
RG   The Freiburg-Warsaw-Columbus pheochromocytoma study group;
RA   Neumann H.P.H., Bausch B., McWhinney S.R., Bender B.U., Gimm O., Franke G.,
RA   Schipper J., Klisch J., Altehoefer C., Zerres K., Januszewicz A.,
RA   Smith W.M., Munk R., Manz T., Glaesker S., Apel T.W., Treier M.,
RA   Reineke M., Walz M.K., Hoang-Vu C., Brauckhoff M., Klein-Franke A.,
RA   Klose P., Schmidt H., Maier-Woelfle M., Peczkowska M., Szmigielski C.,
RA   Eng C.;
RT   "Germ-line mutations in nonsyndromic pheochromocytoma.";
RL   N. Engl. J. Med. 346:1459-1466(2002).
RN   [22]
RP   DISCUSSION OF PATHOGENIC ROLE OF VARIANTS SER-12 AND ARG-50.
RX   PubMed=12696072; DOI=10.1002/gcc.10212;
RA   Cascon A., Ruiz-Llorente S., Cebrian A., Leton R., Telleria D., Benitez J.,
RA   Robledo M.;
RT   "G12S and H50R variations are polymorphisms in the SDHD gene.";
RL   Genes Chromosomes Cancer 37:220-221(2003).
RN   [23]
RP   VARIANTS PPGL1 LEU-81; TYR-92; CYS-114 AND VAL-148.
RX   PubMed=15328326; DOI=10.1001/jama.292.8.943;
RA   Neumann H.P.H., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R.,
RA   Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., Hoegerle S.,
RA   Boedeker C.C., Opocher G., Schipper J., Januszewicz A., Eng C.;
RT   "Distinct clinical features of paraganglioma syndromes associated with SDHB
RT   and SDHD gene mutations.";
RL   JAMA 292:943-951(2004).
RN   [24]
RP   ERRATUM OF PUBMED:15328326.
RA   Neumann H.P.H., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R.,
RA   Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., Hoegerle S.,
RA   Boedeker C.C., Opocher G., Schipper J., Januszewicz A., Eng C.;
RL   JAMA 292:1686-1686(2004).
RN   [25]
RP   VARIANT SER-12.
RX   PubMed=15032977; DOI=10.1111/j..2004.00174.x;
RA   Leube B., Huber R., Goecke T.O., Sandmann W., Royer-Pokora B.;
RT   "SDHD mutation analysis in seven German patients with sporadic carotid body
RT   paraganglioma: one novel mutation, no Dutch founder mutation and further
RT   evidence that G12S is a polymorphism.";
RL   Clin. Genet. 65:61-63(2004).
RN   [26]
RP   INVOLVEMENT IN PGGSS.
RX   PubMed=17804857; DOI=10.1056/nejmc071191;
RA   McWhinney S.R., Pasini B., Stratakis C.A.;
RT   "Familial gastrointestinal stromal tumors and germ-line mutations.";
RL   N. Engl. J. Med. 357:1054-1056(2007).
RN   [27]
RP   VARIANTS SER-12; ARG-50 AND ASN-145, AND CHARACTERIZATION OF VARIANTS
RP   SER-12; ARG-50 AND ASN-145.
RX   PubMed=18678321; DOI=10.1016/j.ajhg.2008.07.011;
RA   Ni Y., Zbuk K.M., Sadler T., Patocs A., Lobo G., Edelman E., Platzer P.,
RA   Orloff M.S., Waite K.A., Eng C.;
RT   "Germline mutations and variants in the succinate dehydrogenase genes in
RT   Cowden and Cowden-like syndromes.";
RL   Am. J. Hum. Genet. 83:261-268(2008).
RN   [28]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-12.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [29]
RP   VARIANT MC2DN3 LYS-69, CHARACTERIZATION OF VARIANT MC2DN3 LYS-69, AND
RP   INVOLVEMENT IN MC2DN3.
RX   PubMed=24367056; DOI=10.1136/jmedgenet-2013-101932;
RA   Jackson C.B., Nuoffer J.M., Hahn D., Prokisch H., Haberberger B.,
RA   Gautschi M., Haeberli A., Gallati S., Schaller A.;
RT   "Mutations in SDHD lead to autosomal recessive encephalomyopathy and
RT   isolated mitochondrial complex II deficiency.";
RL   J. Med. Genet. 51:170-175(2014).
RN   [30]
RP   VARIANT MC2DN3 GLY-92, INVOLVEMENT IN MC2DN3, AND CHARACTERIZATION OF
RP   VARIANT MC2DN3 GLY-92.
RX   PubMed=26008905; DOI=10.1007/s00439-015-1568-z;
RA   Alston C.L., Ceccatelli Berti C., Blakely E.L., Olahova M., He L.,
RA   McMahon C.J., Olpin S.E., Hargreaves I.P., Nolli C., McFarland R.,
RA   Goffrini P., O'Sullivan M.J., Taylor R.W.;
RT   "A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal
RT   cardiomyopathy and a severe mitochondrial complex II deficiency.";
RL   Hum. Genet. 134:869-879(2015).
CC   -!- FUNCTION: Membrane-anchoring subunit of succinate dehydrogenase (SDH)
CC       that is involved in complex II of the mitochondrial electron transport
CC       chain and is responsible for transferring electrons from succinate to
CC       ubiquinone (coenzyme Q) (PubMed:10482792, PubMed:9533030). SDH also
CC       oxidizes malate to the non-canonical enol form of oxaloacetate, enol-
CC       oxaloacetate (By similarity). Enol-oxaloacetate, which is a potent
CC       inhibitor of the succinate dehydrogenase activity, is further
CC       isomerized into keto-oxaloacetate (By similarity).
CC       {ECO:0000250|UniProtKB:Q95123, ECO:0000269|PubMed:10482792,
CC       ECO:0000269|PubMed:9533030}.
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle.
CC       {ECO:0000269|PubMed:10482792, ECO:0000269|PubMed:9533030}.
CC   -!- SUBUNIT: Component of complex II composed of four subunits: the
CC       flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a cytochrome
CC       b560 composed of SDHC and SDHD. {ECO:0000269|PubMed:37098072}.
CC   -!- INTERACTION:
CC       O14521; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-1224553, EBI-17589229;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:37098072, ECO:0000269|PubMed:9533030}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O14521-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14521-2; Sequence=VSP_054744;
CC       Name=3;
CC         IsoId=O14521-3; Sequence=VSP_054745;
CC       Name=4;
CC         IsoId=O14521-4; Sequence=VSP_054746, VSP_054747;
CC   -!- DISEASE: Pheochromocytoma/paraganglioma syndrome 1 (PPGL1)
CC       [MIM:168000]: A form of pheochromocytoma/paraganglioma syndrome, a
CC       tumor predisposition syndrome characterized by the development of
CC       neuroendocrine tumors, usually in adulthood. Pheochromocytomas are
CC       catecholamine-producing tumors that arise from chromaffin cells in the
CC       adrenal medulla. Paragangliomas develop from sympathetic paraganglia in
CC       the thorax, abdomen, and pelvis, as well as from parasympathetic
CC       paraganglia in the head and neck. PPGL1 inheritance is autosomal
CC       dominant. {ECO:0000269|PubMed:10657297, ECO:0000269|PubMed:11156372,
CC       ECO:0000269|PubMed:11343322, ECO:0000269|PubMed:11391796,
CC       ECO:0000269|PubMed:11391798, ECO:0000269|PubMed:12000816,
CC       ECO:0000269|PubMed:15328326}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Paraganglioma and gastric stromal sarcoma (PGGSS)
CC       [MIM:606864]: Gastrointestinal stromal tumors may be sporadic or
CC       inherited in an autosomal dominant manner, alone or as a component of a
CC       syndrome associated with other tumors, such as in the context of
CC       neurofibromatosis type 1 (NF1). Patients have both gastrointestinal
CC       stromal tumors and paragangliomas. Susceptibility to the tumors was
CC       inherited in an apparently autosomal dominant manner, with incomplete
CC       penetrance. {ECO:0000269|PubMed:17804857}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial complex II deficiency, nuclear type 3 (MC2DN3)
CC       [MIM:619167]: A form of mitochondrial complex II deficiency, a disorder
CC       with heterogeneous clinical manifestations. Some patients have
CC       multisystem involvement of the brain, heart, muscle, liver, and kidneys
CC       resulting in death in infancy, whereas others have only isolated
CC       cardiac or muscle involvement with onset in adulthood and normal
CC       cognition. Clinical features include psychomotor regression in infants,
CC       poor growth with lack of speech development, severe spastic
CC       quadriplegia, dystonia, progressive leukoencephalopathy, muscle
CC       weakness, exercise intolerance, cardiomyopathy. Some patients manifest
CC       Leigh syndrome or Kearns-Sayre syndrome. MC2DN3 inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:24367056,
CC       ECO:0000269|PubMed:26008905}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CybS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/390/SDHD";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=SDHD entry;
CC       URL="https://en.wikipedia.org/wiki/SDHD";
CC   -!- WEB RESOURCE: Name=TCA Cycle Gene Mutation Database;
CC       URL="https://databases.lovd.nl/shared/genes/SDHD";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB006202; BAA22054.1; -; mRNA.
DR   EMBL; AB026906; BAA81889.1; -; Genomic_DNA.
DR   EMBL; AK075360; BAG52120.1; -; mRNA.
DR   EMBL; BT007238; AAP35902.1; -; mRNA.
DR   EMBL; CR456932; CAG33213.1; -; mRNA.
DR   EMBL; AP002007; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67181.1; -; Genomic_DNA.
DR   EMBL; BC005263; AAH05263.1; -; mRNA.
DR   EMBL; BC009574; AAH09574.1; -; mRNA.
DR   EMBL; BC012603; AAH12603.1; -; mRNA.
DR   EMBL; BC015188; AAH15188.1; -; mRNA.
DR   EMBL; BC015992; AAH15992.1; -; mRNA.
DR   EMBL; BC022350; AAH22350.1; -; mRNA.
DR   EMBL; BC070307; AAH70307.1; -; mRNA.
DR   EMBL; BC071755; AAH71755.1; -; mRNA.
DR   EMBL; BC071756; AAH71756.1; -; mRNA.
DR   CCDS; CCDS31678.1; -. [O14521-1]
DR   CCDS; CCDS60958.1; -. [O14521-4]
DR   CCDS; CCDS60959.1; -. [O14521-3]
DR   CCDS; CCDS60960.1; -. [O14521-2]
DR   RefSeq; NP_001263432.1; NM_001276503.2. [O14521-3]
DR   RefSeq; NP_001263433.1; NM_001276504.2. [O14521-2]
DR   RefSeq; NP_001263435.1; NM_001276506.2. [O14521-4]
DR   RefSeq; NP_002993.1; NM_003002.4. [O14521-1]
DR   PDB; 8GS8; EM; 2.86 A; D=1-159.
DR   PDBsum; 8GS8; -.
DR   AlphaFoldDB; O14521; -.
DR   EMDB; EMD-34225; -.
DR   SMR; O14521; -.
DR   BioGRID; 112293; 31.
DR   ComplexPortal; CPX-561; Mitochondrial respiratory chain complex II.
DR   FunCoup; O14521; 1586.
DR   IntAct; O14521; 21.
DR   MINT; O14521; -.
DR   STRING; 9606.ENSP00000364699; -.
DR   DrugBank; DB04141; 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol.
DR   DrugBank; DB00756; Hexachlorophene.
DR   DrugBank; DB08689; Ubiquinone Q1.
DR   TCDB; 3.D.10.1.7; the prokaryotic succinate dehydrogenase (sdh) family.
DR   GlyGen; O14521; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O14521; -.
DR   SwissPalm; O14521; -.
DR   BioMuta; SDHD; -.
DR   jPOST; O14521; -.
DR   MassIVE; O14521; -.
DR   PaxDb; 9606-ENSP00000364699; -.
DR   PeptideAtlas; O14521; -.
DR   ProteomicsDB; 20759; -.
DR   ProteomicsDB; 20802; -.
DR   ProteomicsDB; 48064; -. [O14521-1]
DR   Pumba; O14521; -.
DR   TopDownProteomics; O14521-1; -. [O14521-1]
DR   Antibodypedia; 32123; 139 antibodies from 29 providers.
DR   DNASU; 6392; -.
DR   Ensembl; ENST00000375549.8; ENSP00000364699.3; ENSG00000204370.15. [O14521-1]
DR   Ensembl; ENST00000525291.5; ENSP00000436669.1; ENSG00000204370.15. [O14521-2]
DR   Ensembl; ENST00000526592.5; ENSP00000432005.1; ENSG00000204370.15. [O14521-4]
DR   Ensembl; ENST00000528048.5; ENSP00000436217.1; ENSG00000204370.15. [O14521-3]
DR   GeneID; 6392; -.
DR   KEGG; hsa:6392; -.
DR   MANE-Select; ENST00000375549.8; ENSP00000364699.3; NM_003002.4; NP_002993.1.
DR   UCSC; uc001pmz.5; human. [O14521-1]
DR   AGR; HGNC:10683; -.
DR   ClinPGx; PA35608; -.
DR   CTD; 6392; -.
DR   DisGeNET; 6392; -.
DR   GeneCards; SDHD; -.
DR   GeneReviews; SDHD; -.
DR   HGNC; HGNC:10683; SDHD.
DR   HPA; ENSG00000204370; Low tissue specificity.
DR   MalaCards; SDHD; -.
DR   MIM; 168000; phenotype.
DR   MIM; 602690; gene.
DR   MIM; 606864; phenotype.
DR   MIM; 619167; phenotype.
DR   OpenTargets; ENSG00000204370; -.
DR   Orphanet; 100093; Carcinoid syndrome.
DR   Orphanet; 97286; Carney-Stratakis syndrome.
DR   Orphanet; 201; Cowden syndrome.
DR   Orphanet; 29072; Hereditary pheochromocytoma-paraganglioma.
DR   Orphanet; 3208; Isolated succinate-CoQ reductase deficiency.
DR   Orphanet; 276621; Sporadic pheochromocytoma/secreting paraganglioma.
DR   VEuPathDB; HostDB:ENSG00000204370; -.
DR   eggNOG; KOG4097; Eukaryota.
DR   GeneTree; ENSGT00390000010003; -.
DR   HOGENOM; CLU_2512011_0_0_1; -.
DR   InParanoid; O14521; -.
DR   OMA; VMHQHWG; -.
DR   OrthoDB; 18577at2759; -.
DR   PAN-GO; O14521; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; O14521; -.
DR   BioCyc; MetaCyc:ENSG00000150781-MONOMER; -.
DR   PathwayCommons; O14521; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   Reactome; R-HSA-9854311; Maturation of TCA enzymes and regulation of TCA cycle.
DR   SignaLink; O14521; -.
DR   SIGNOR; O14521; -.
DR   UniPathway; UPA00223; -.
DR   Agora; ENSG00000204370; -.
DR   BioGRID-ORCS; 6392; 521 hits in 1170 CRISPR screens.
DR   ChiTaRS; SDHD; human.
DR   GeneWiki; SDHD; -.
DR   GenomeRNAi; 6392; -.
DR   Pharos; O14521; Tbio.
DR   PRO; PR:O14521; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O14521; protein.
DR   Bgee; ENSG00000204370; Expressed in jejunal mucosa and 203 other cell types or tissues.
DR   ExpressionAtlas; O14521; baseline and differential.
DR   GO; GO:0005740; C:mitochondrial envelope; TAS:ProtInc.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HTP:FlyBase.
DR   GO; GO:0045273; C:respiratory chain complex II (succinate dehydrogenase); IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008177; F:succinate dehydrogenase (quinone) activity; IEA:Ensembl.
DR   GO; GO:0048039; F:ubiquinone binding; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IBA:GO_Central.
DR   GO; GO:0042776; P:proton motive force-driven mitochondrial ATP synthesis; NAS:ComplexPortal.
DR   GO; GO:0050433; P:regulation of catecholamine secretion; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB.
DR   CDD; cd03496; SQR_TypeC_CybS; 1.
DR   FunFam; 1.20.1300.10:FF:000009; Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial; 1.
DR   Gene3D; 1.20.1300.10; Fumarate reductase/succinate dehydrogenase, transmembrane subunit; 1.
DR   InterPro; IPR007992; CybS.
DR   InterPro; IPR034804; SQR/QFR_C/D.
DR   PANTHER; PTHR13337; SUCCINATE DEHYDROGENASE; 1.
DR   PANTHER; PTHR13337:SF6; SUCCINATE DEHYDROGENASE [UBIQUINONE] CYTOCHROME B SMALL SUBUNIT, MITOCHONDRIAL; 1.
DR   Pfam; PF05328; CybS; 1.
DR   SUPFAM; SSF81343; Fumarate reductase respiratory complex transmembrane subunits; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disease variant; Electron transport;
KW   Heme; Iron; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion inner membrane; Primary mitochondrial disease;
KW   Proteomics identification; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix; Transport; Tricarboxylic acid cycle.
FT   TRANSIT         1..56
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           57..159
FT                   /note="Succinate dehydrogenase [ubiquinone] cytochrome b
FT                   small subunit, mitochondrial"
FT                   /id="PRO_0000006487"
FT   TOPO_DOM        57..63
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TRANSMEM        64..85
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TOPO_DOM        86..90
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TRANSMEM        91..111
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TOPO_DOM        112..122
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TRANSMEM        123..144
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   TOPO_DOM        145..159
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   BINDING         102
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_note="ligand shared with SDHC"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   BINDING         114
FT                   /ligand="a ubiquinone"
FT                   /ligand_id="ChEBI:CHEBI:16389"
FT                   /ligand_note="ligand shared with IP/SDHB"
FT                   /evidence="ECO:0000269|PubMed:37098072,
FT                   ECO:0007744|PDB:8GS8"
FT   VAR_SEQ         19..57
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054744"
FT   VAR_SEQ         56..158
FT                   /note="HSGSKAASLHWTSERVVSVLLLGLLPAAYLNPCSAMDYSLAAALTLHGHWGL
FT                   GQVVTDYVHGDALQKAAKAGLLALSALTFAGLCYFNYHDVGICKAVAMLWK -> HWAL
FT                   DKLLLTMFMGMPCRKLPRQGFWHFQ (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054745"
FT   VAR_SEQ         106..143
FT                   /note="GLGQVVTDYVHGDALQKAAKAGLLALSALTFAGLCYFN -> LECNGAILAR
FT                   HDLGSARSQLTATSAFRVQAILLPQPPK (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054746"
FT   VAR_SEQ         144..159
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054747"
FT   VARIANT         12
FT                   /note="G -> S (probable risk factor for pheochromocytoma,
FT                   paraganglioma, intestinal carcinoid tumor and breast, renal
FT                   and uterus carcinoma; increased manganese superoxide
FT                   dismutase expression and increased reactive oxygen species;
FT                   results in 1.9-fold increase in both AKT and MAPK
FT                   expression; dbSNP:rs34677591)"
FT                   /evidence="ECO:0000269|PubMed:11526495,
FT                   ECO:0000269|PubMed:12007193, ECO:0000269|PubMed:12696072,
FT                   ECO:0000269|PubMed:14500403, ECO:0000269|PubMed:15032977,
FT                   ECO:0000269|PubMed:18678321, ECO:0000269|PubMed:18987736"
FT                   /id="VAR_017870"
FT   VARIANT         50
FT                   /note="H -> R (probable risk factor for paraganglioma,
FT                   breast and thyroid carcinoma; may be involved in somatic
FT                   Merkel cell carcinoma; increased manganese superoxide
FT                   dismutase expression and increased reactive oxygen species;
FT                   results in a 2.0-fold increase in AKT expression and a
FT                   1.7-fold increase in MAPK expression; dbSNP:rs11214077)"
FT                   /evidence="ECO:0000269|PubMed:12007193,
FT                   ECO:0000269|PubMed:12696072, ECO:0000269|PubMed:14500403,
FT                   ECO:0000269|PubMed:18678321"
FT                   /id="VAR_017871"
FT   VARIANT         69
FT                   /note="E -> K (in MC2DN3; results in impaired mitochondrial
FT                   complex II assembly; results in impaired cellular
FT                   respiration; dbSNP:rs202198133)"
FT                   /evidence="ECO:0000269|PubMed:24367056"
FT                   /id="VAR_074105"
FT   VARIANT         81
FT                   /note="P -> L (in PPGL1; dbSNP:rs80338844)"
FT                   /evidence="ECO:0000269|PubMed:10657297,
FT                   ECO:0000269|PubMed:11156372, ECO:0000269|PubMed:15328326"
FT                   /id="VAR_010038"
FT   VARIANT         92
FT                   /note="D -> G (in MC2DN3; results in highly reduced protein
FT                   expression; results in impaired cellular respiration;
FT                   dbSNP:rs786205436)"
FT                   /evidence="ECO:0000269|PubMed:26008905"
FT                   /id="VAR_074106"
FT   VARIANT         92
FT                   /note="D -> Y (in PPGL1; dbSNP:rs80338845)"
FT                   /evidence="ECO:0000269|PubMed:10657297,
FT                   ECO:0000269|PubMed:11391798, ECO:0000269|PubMed:12000816,
FT                   ECO:0000269|PubMed:15328326"
FT                   /id="VAR_010039"
FT   VARIANT         93
FT                   /note="Missing (in PPGL1; dbSNP:rs121908983)"
FT                   /evidence="ECO:0000269|PubMed:11391796"
FT                   /id="VAR_018519"
FT   VARIANT         102
FT                   /note="H -> L (in PPGL1; dbSNP:rs104894302)"
FT                   /evidence="ECO:0000269|PubMed:10657297"
FT                   /id="VAR_010040"
FT   VARIANT         114
FT                   /note="Y -> C (in PPGL1; dbSNP:rs104894304)"
FT                   /evidence="ECO:0000269|PubMed:11343322,
FT                   ECO:0000269|PubMed:15328326"
FT                   /id="VAR_017872"
FT   VARIANT         139
FT                   /note="L -> P (in PPGL1; dbSNP:rs80338847)"
FT                   /evidence="ECO:0000269|PubMed:11391798"
FT                   /id="VAR_017873"
FT   VARIANT         145
FT                   /note="H -> N (found in an individual with features of
FT                   Cowden syndrome; uncertain significance; increased
FT                   manganese superoxide dismutase expression and normal
FT                   reactive oxygen species; no change in AKT expression but a
FT                   1.2-fold increase of MAPK expression; dbSNP:rs121908984)"
FT                   /evidence="ECO:0000269|PubMed:18678321"
FT                   /id="VAR_054384"
FT   VARIANT         148
FT                   /note="G -> V (in PPGL1; dbSNP:rs1555187633)"
FT                   /evidence="ECO:0000269|PubMed:15328326"
FT                   /id="VAR_054385"
FT   CONFLICT        74
FT                   /note="V -> F (in Ref. 8; AAH70307)"
FT                   /evidence="ECO:0000305"
FT   HELIX           63..79
FT                   /evidence="ECO:0007829|PDB:8GS8"
FT   HELIX           81..85
FT                   /evidence="ECO:0007829|PDB:8GS8"
FT   HELIX           89..114
FT                   /evidence="ECO:0007829|PDB:8GS8"
FT   HELIX           118..145
FT                   /evidence="ECO:0007829|PDB:8GS8"
FT   HELIX           148..156
FT                   /evidence="ECO:0007829|PDB:8GS8"
SQ   SEQUENCE   159 AA;  17043 MW;  6B1AA94831C8C3B6 CRC64;
     MAVLWRLSAV CGALGGRALL LRTPVVRPAH ISAFLQDRPI PEWCGVQHIH LSPSHHSGSK
     AASLHWTSER VVSVLLLGLL PAAYLNPCSA MDYSLAAALT LHGHWGLGQV VTDYVHGDAL
     QKAAKAGLLA LSALTFAGLC YFNYHDVGIC KAVAMLWKL
//
